How should I manage a 36-year-old male construction worker with diffuse muscle stiffness, no prior medical history, who uses marijuana for sleep, is not on any medications, and has elevated C-reactive protein, low ferritin, elevated LDL cholesterol, borderline vitamin D insufficiency, and mild leukocytosis?

Management of Diffuse Muscle Stiffness with Multiple Laboratory Abnormalities

This patient requires a systematic workup for secondary causes of muscle stiffness before any other intervention, with immediate attention to iron deficiency anemia, vitamin D insufficiency, and evaluation for underlying inflammatory or rheumatologic conditions.

Immediate Diagnostic Priorities

The constellation of diffuse muscle stiffness, elevated CRP (11.7 mg/L), low ferritin (19 ng/mL), borderline vitamin D (29.2 ng/mL), and mild leukocytosis demands evaluation for conditions that can cause muscle symptoms before attributing symptoms to occupational factors or marijuana use 1.

Critical Workup Required

Check the following labs immediately:

• Creatine kinase (CK) - to rule out inflammatory myopathy or rhabdomyolysis
• TSH - hypothyroidism commonly causes muscle stiffness and can elevate CRP
• Complete metabolic panel - assess renal and hepatic function
• ESR - if markedly elevated with CRP, consider polymyalgia rheumatica (PMR) in the differential despite young age 1
• Complete blood count with differential - characterize the leukocytosis (WBC 11.8)

The ACC/AHA guidelines explicitly state that when evaluating muscle symptoms, you must "evaluate the patient for other conditions that might increase the risk for muscle symptoms (e.g., hypothyroidism, reduced renal or hepatic function, rheumatologic disorders such as polymyalgia rheumatica, steroid myopathy, vitamin D deficiency, or primary muscle diseases)" 1.

Address Nutritional Deficiencies

Iron Deficiency

Ferritin of 19 ng/mL is significantly low and requires treatment. This level of iron deficiency can contribute to fatigue and potentially muscle symptoms. Start oral iron supplementation (ferrous sulfate 325 mg daily or every other day for better tolerance). Investigate the cause - dietary insufficiency vs. occult GI blood loss, particularly given his construction work and potential NSAID use for muscle pain.

Vitamin D Insufficiency

Vitamin D level of 29.2 ng/mL is insufficient and directly linked to muscle symptoms 1. Vitamin D deficiency is specifically mentioned in ACC/AHA guidelines as a cause of muscle stiffness and is a mediator of inflammation 2.

• Start vitamin D3 supplementation: 2,000-4,000 IU daily
• Target level >30 ng/mL, ideally 40-50 ng/mL
• Recheck in 8-12 weeks

Recent evidence demonstrates that vitamin D deficiency mediates the relationship between dietary patterns and inflammatory markers like CRP 2, making correction particularly important given his elevated CRP.

Elevated CRP and Inflammation

CRP of 11.7 mg/L indicates significant systemic inflammation (normal <3 mg/L) and places him at increased cardiovascular risk 3. This level is too high to attribute solely to occupational strain.

Differential considerations:

• Rheumatologic conditions - PMR, inflammatory myopathies (though typically older patients for PMR) 1, 4, 5
• Infectious causes - given leukocytosis, consider occult infection 5
• Inflammatory myopathy - dermatomyositis, polymyositis (check CK, aldolase, consider ANA, myositis panel if CK elevated) 4
• Occupational overuse - but would not typically cause CRP this elevated

Marijuana Use Considerations

Marijuana use for sleep is not causing his muscle stiffness or laboratory abnormalities. Research shows:

• No significant association between marijuana use and elevated CRP in most populations 6, 7
• Some studies suggest marijuana may be associated with lower CRP levels 7, 8, though this effect is inconsistent
• No evidence linking marijuana to muscle stiffness syndromes 9

However, address sleep hygiene and consider cognitive behavioral therapy for insomnia as a more evidence-based approach than marijuana.

Cardiovascular Risk Management

LDL of 151 mg/dL requires risk stratification but NOT immediate statin therapy given his age and lack of other major risk factors 10.

Calculate his 10-year ASCVD risk using the pooled cohort equation:

• If risk ≥7.5%, have a clinician-patient risk discussion about moderate-intensity statin 10
• If risk 5-7.5% (borderline), his elevated CRP (>2 mg/L) is a risk-enhancing factor that may favor statin therapy 10
• Do NOT start a statin until muscle symptoms are fully evaluated and resolved - starting a statin now would confound the diagnostic workup 1

The 2018 ACC/AHA guidelines emphasize that risk-enhancing factors include "persistent elevations of high-sensitivity C-reactive protein ≥2.0 mg/L" 10, which applies to this patient.

Management Algorithm

Week 1-2:

1. Order: CK, TSH, CMP, ESR, CBC with differential
2. Start: Iron supplementation, vitamin D3 2,000-4,000 IU daily
3. Counsel: Sleep hygiene, avoid statin initiation until workup complete

Week 4-6:

1. Review all laboratory results
2. If CK elevated >10x ULN or concerning for myopathy: refer to neurology/rheumatology
3. If TSH abnormal: treat hypothyroidism
4. If ESR markedly elevated with normal CK: consider rheumatology referral for possible PMR or other inflammatory condition
5. Recheck CRP, ferritin

Week 8-12:

1. After muscle symptoms evaluated/treated and vitamin D/iron repleted, reassess cardiovascular risk
2. Calculate 10-year ASCVD risk
3. If statin indicated, ensure baseline muscle symptoms documented before initiation 1

Critical Pitfalls to Avoid

• Do not attribute muscle stiffness to occupational factors alone with CRP this elevated
• Do not start a statin before completing muscle symptom workup - this violates ACC/AHA recommendations and will confound diagnosis 1
• Do not dismiss low ferritin - this requires investigation and treatment
• Do not blame marijuana - no evidence supports this as causative for his presentation
• Do not delay rheumatology referral if CK is elevated or ESR is markedly elevated with persistent symptoms despite vitamin D/iron repletion